Hydroxymethyl Dasatinib,
910297-58-4,
UNII-O4S6Z9X0XS,
O4S6Z9X0XS,
N-(2-Chloro-6-(hydroxymethyl)phenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-5-thiazolecarboxamide,
N-[2-CHLORO-6-(HYDROXYMETHYL)PHENYL]-2-[[6-[4-(2-HYDROXYETHYL)-(PIPERAZIN-1-YL)]-2-METHYL-PYRIMIDIN-4-YL]AMINO]-5-THIAZOLECARBOXAMIDE,
Dasatinib metabolite M24,
N-[2-Chloro-6-(hydroxymethyl)phenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide,
BMS-749426,
SCHEMBL1705125,
CTK5G8816,
DTXSID90474433,
KZNOWBHQESWSTD-UHFFFAOYSA-N,
ZINC22060813,
AKOS030255280,
5-Thiazolecarboxamide, N-(2-chloro-6-(hydroxymethyl)phenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-,
N-(2-Chloro-6-(hydroxymethyl)phenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methyl-pyrimidin-4-yl)amino)thiazole-5-carboxamide,
RT-013286,
FT-0669779,
n-(2-chloro-6-(hydroxymethyl)phenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,
HydroxymethylDasatinib,
CID11854534,
CID 11854534,